US Physicalrapy Inc (USPH)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 11.37 | 11.32 | 11.48 | 11.05 | 11.66 | 11.16 | 10.70 | 10.06 | 10.65 | 10.89 | 10.45 | 10.43 | 10.36 | 10.51 | 10.40 | 9.39 | 10.18 | 10.79 | 12.10 | 11.22 | |
| DSO | days | 32.10 | 32.23 | 31.78 | 33.02 | 31.30 | 32.70 | 34.12 | 36.28 | 34.27 | 33.51 | 34.94 | 35.01 | 35.22 | 34.72 | 35.10 | 38.86 | 35.85 | 33.82 | 30.17 | 32.54 |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 11.37
= 32.10
Based on the provided data, US Physicalrapy Inc's Days of Sales Outstanding (DSO) has fluctuated over the reported periods. DSO represents the average number of days it takes for the company to collect on its accounts receivable. A lower DSO indicates a faster collection of receivables, which is favorable for the company's cash flow.
US Physicalrapy Inc's DSO ranged from a low of 30.17 days on June 30, 2020, to a high of 38.86 days on March 31, 2021. The company experienced an increase in DSO during the first half of 2021 but managed to lower it in subsequent periods. Notably, the DSO for December 31, 2024, stood at 32.10 days, showing an improvement from the Q1 2021 peak.
Overall, US Physicalrapy Inc's management of accounts receivable collection appears relatively efficient, as the DSO remained within a moderate range throughout the reported periods. However, the company should continue to monitor and potentially improve its receivables management to ensure timely collections and maintain healthy cash flows.
Peer comparison
Dec 31, 2024